June 27, 2017 / 11:22 AM / 2 months ago

BRIEF-Neuroderm updates on ND0612H phase II trial

June 27 (Reuters) - Neuroderm Ltd:

* Results of Neuroderm’s ND0612H phase II trial presented in oral session at the 3rd congress of the European academy of neurology

* Neuroderm Ltd says both R1 and R2 regimens were well tolerated Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below